tiprankstipranks
Trending News
More News >
Q32 Bio Inc’s Intellectual Property Challenges: Navigating Risks and Competitive Pressures
PremiumCompany AnnouncementsQ32 Bio Inc’s Intellectual Property Challenges: Navigating Risks and Competitive Pressures
3M ago
Q32 Bio Reports Promising Trial Results and Financials
Premium
Company Announcements
Q32 Bio Reports Promising Trial Results and Financials
3M ago
Q32 Bio presents results from SIGNAL-AA Part 2a trial of bempikibart
Premium
The Fly
Q32 Bio presents results from SIGNAL-AA Part 2a trial of bempikibart
3M ago
Q32 Bio Restructures to Focus on Bempikibart Development
PremiumCompany AnnouncementsQ32 Bio Restructures to Focus on Bempikibart Development
4M ago
Q32 Bio announces corporate restructuring to focus on bempikibart
Premium
The Fly
Q32 Bio announces corporate restructuring to focus on bempikibart
4M ago
Q32 Bio Advances Clinical Trials for Growth Opportunities
Premium
Company Announcements
Q32 Bio Advances Clinical Trials for Growth Opportunities
5M ago
Q32 Bio Announces Mixed Results in Clinical Trials
PremiumCompany AnnouncementsQ32 Bio Announces Mixed Results in Clinical Trials
6M ago
Q32 Bio price target lowered to $20 from $85 at Piper Sandler
Premium
The Fly
Q32 Bio price target lowered to $20 from $85 at Piper Sandler
6M ago
Q32 Bio downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Q32 Bio downgraded to Market Perform from Outperform at Leerink
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100